Total Valuation
Oncologix Tech has a market cap or net worth of $166.25K. The enterprise value is $73.66K.
Market Cap$166.25K
Enterprise Value$73.66K
Share Statistics
Oncologix Tech has 1,662,469,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,662,469,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Oncologix Tech’s return on equity (ROE) is 0.40 and return on invested capital (ROIC) is 106.15%.
Return on Equity (ROE)0.40
Return on Assets (ROA)-1.59
Return on Invested Capital (ROIC)106.15%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee14.92K
Profits Per Employee-12.41K
Employee Count191
Asset Turnover1.91
Inventory Turnover759.67
Valuation Ratios
The current PE Ratio of Oncologix Tech is ―. Oncologix Tech’s PEG ratio is -0.00404.
PE Ratio―
PS Ratio0.08
PB Ratio-0.04
Price to Fair Value-0.04
Price to FCF-8.80
Price to Operating Cash Flow-3.04
PEG Ratio-0.00404
Income Statement
In the last 12 months, Oncologix Tech had revenue of 2.85M and earned -2.37M in profits. Earnings per share was >-0.01.
Revenue2.85M
Gross Profit571.56K
Operating Income-865.00K
Pretax Income-2.37M
Net Income-2.37M
EBITDA-1.11M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -18.77K and capital expenditures 0.00, giving a free cash flow of -18.77K billion.
Operating Cash Flow-18.77K
Free Cash Flow-18.77K
Free Cash Flow per Share>-0.01
Dividends & Yields
Oncologix Tech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-14.94
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)―
Important Dates
Oncologix Tech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Oncologix Tech as a current ratio of 0.03, with Debt / Equity ratio of 0.00%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap23.33
Net Debt to EBITDA-4.62
Interest Coverage Ratio-0.69
Taxes
In the past 12 months, Oncologix Tech has paid 3.00 in taxes.
Income Tax3.00
Effective Tax Rate>-0.01
Enterprise Valuation
Oncologix Tech EV to EBITDA ratio is -4.82, with an EV/FCF ratio of -212.82.
EV to Sales1.88
EV to EBITDA-4.82
EV to Free Cash Flow-212.82
EV to Operating Cash Flow-220.85
Balance Sheet
Oncologix Tech has $4.85K in cash and marketable securities with $23.62K in debt, giving a net cash position of -$18.77K billion.
Cash & Marketable Securities$4.85K
Total Debt$23.62K
Net Cash-$18.77K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.01
Margins
Gross margin is 20.05%, with operating margin of -30.35%, and net profit margin of -83.19%.
Gross Margin20.05%
Operating Margin-30.35%
Pretax Margin-83.19%
Net Profit Margin-83.19%
EBITDA Margin-38.95%
EBIT Margin-39.47%
Analyst Forecast
The average price target for Oncologix Tech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―